Practice question

Answer the question and get instant feedback.

ModerateEndocrinologyObesity pharmacotherapyus-abimus-abfm

A 50-year-old woman with BMI 37 kg/m² and T2D asks about weight-loss pharmacotherapy. Which option has the strongest evidence for ≥10% weight loss with cardiometabolic benefit?

Educational content. Not a substitute for clinical judgement or local policy.